Botulism, where are we now?

Clinical Toxicology

Volumn 48, Issue 9, 2010, Pages 867-879

  Zhang, Jiu Cong ^a   Sun, Li ^a   Nie, Qing He ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Botulinum toxin; Botulism; Clinical sign and symptoms; Clostridium botulinum; Diagnosis; Prevention; Treatment; Vaccine research

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM ANTISERUM; BOTULISM VACCINE; UNCLASSIFIED DRUG; VACCINE;

BOTULISM; CLINICAL FEATURE; CLOSTRIDIUM BOTULINUM; DIAGNOSTIC TEST; DISEASE CONTROL; HUMAN; NONHUMAN; PROPHYLAXIS; REVIEW; SYMPTOM;

BACTERIAL VACCINES; BOTULINUM TOXINS; BOTULISM; CLOSTRIDIUM BOTULINUM; HUMANS;

CLOSTRIDIUM BOTULINUM;

EID: 78650483420     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2010.535003     Document Type: Review

References (148)

1. Smith LD, Sugiyama H. Botulism: The Organism, Its Toxins, The Disease. 2nd ed. Springfield, IL: Charles C. Thomas; 1988.
2. Meyer KF. The rise and fall of botulism. Calif Med 1973; 118: 63-64.
3. Dembek ZF, Smith LA, Rusnak JM. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep 2007; 1: 122-134.
4. Sobel J. Diagnosis and treatment of botulism: a century later, clinical suspicion remains the cornerstone. Clin Infect Dis 2009; 48: 1674-1675.
5. Cherington M. Botulism: update and review. Semin Neurol 2004; 24: 155-163.
6. Erbguth FJ, Naumann M. On the first systematic descriptions of botulism and botulinum toxin by Justinus Kerner (1786-1862). J Hist Neurosci 2000; 9: 218-220.
7. Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison". Neurology 1999; 53: 1850-1853.
8. Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 2004; 19 (Suppl 8):S2-S6.
9. Torrens JK. Clostridium botulinum was named because of association with "sausage poisoning." BMJ 1998; 316: 151.
10. van Ermengem E. Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism.
11. E. van Ermengem. Originally published as "Ueber einen neuen anaëroben Bacillus und seine Bezie-hungen zum Botulismus" in Zeitschrift für Hygiene und Infektion-skrankheiten 26: 1-56, 1897. Rev Infect Dis 1979; 1: 701-719.
12. Snipe PT, Sommer H. Studies on botulinus toxin: 3. Acid precipitation of botulinus toxin. J Infect Dis 1928; 43: 152-160.
13. Burgen AS, Dickens F, Zatman LJ. The action of botulinum toxin on the neuromuscular junction. J Physiol 1949; 109: 10-24.
14. Scott AB. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology. Ophthalmology 1989; Suppl: 37-41.
15. Bushara KO, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatr 1994; 57: 1437-1438.
16. Erbguth FJ. From poison to remedy: the chequered history of botulinum toxin. J Neural Transm 2008; 115: 559-565.
17. Freeman SR, Cohen JL. New neurotoxins on the horizon. Aesthet Surg J. 2008, 28, 325-330.
18. Erbguth FJ. Botulinum toxin, a historical note. Lancet 1998; 351: 1820.
19. Hatheway CL. Toxigenic clostridia. Clin Microbiol Rev 1990; 3: 66-98.
20. Giménez DF, Ciccarelli AS. Another type of Clostridium botulinum. Zentralbl Bakteriol Orig 1970; 215: 221-224.
21. Sharma SK, Whiting RC. Methods for detection of Clostridium botulinum toxin in foods. J Food Prot 2005; 68: 1256-1263.
22. St Louis ME, Peck SH, Bowering D, Morgan GB, Blatherwick J, Banerjee S, et al. Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med 1988; 108: 363-368.
23. Angulo FJ, Getz J, Taylor JP, Hendricks KA, Hatheway CL, Barth SS, et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 1998; 178: 172-177.
24. Wenham TN. Botulism: a rare complication of injecting drug use. Emerg Med J 2008; 25: 55-56.
25. Merson MH, Dowell VR. Epidemiologic, clinical, and laboratory aspects of wound botulism. New Eng J Med 1973; 289: 1005-1010.
26. Keller MA, Miller VH, Berkowitz CD, Yoshimori RN. Wound botulism in pediatrics. Am J Dis Child 1982; 136: 320-322.
27. Burningham MD, Walter FG, Mechem C, Haber J, Ekins BR. Wound botulism. Ann Emerg Med 1994; 24: 1184-1187. (Pubitemid 24368164)
28. Thomas GL, Haji-Michael PG. Wound botulism in an injecting drug abuser. Intensive Care Med 2003; 29:857.
29. Arnon SS, Midura TF, Clay SA, Wood RM, Chin J. Infant botulism: epidemiological, clinical, and laboratory aspects. JAMA 1977; 237: 1946-1951.
30. Centers for Disease Control and Prevention (CDC). Infant botulism-New York City, 2001-2002. MMWR Morb Mortal Wkly Rep 2003; 52: 21-24.
31. Arnon SS. Infant botulism. In: Rudolph AM, Hoffman JI, Rudolph CD, editors. Rudolph's Pediatrics. 20th ed. New York: Appleton & Lange; 1996:555-558.
32. Arnon SS, Midura TF, Damus K, Thompson B, Wood RM, Chin J. Honey and other environmental risk factors for infant botulism. J Pediatr 1979; 94: 331-336.
33. Pickett J, Berg B, Chaplin E, Brunstetter-Shafer MA. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med 1976; 295: 770-772.
34. Bakheit AM, Ward CD, McLellan DL. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. J Neurol Neurosurg Psychiatry 1997; 62:198.
35. Middlebrook JL, Franz DR. Botulinum toxins. In: Sidell FR, Takafuji ET, Franz DR, editors. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, Department of the Army; 1997:643-654.
36. Zilinskas RA. Iraq's biological weapons: the past as future? JAMA 1997; 278: 418-424.
37. Merson MH, Hughes JM, Dowell VR, Taylor A, Barker WH, Gangarosa EJ. Current trends in botulism in the United States. JAMA 1974; 229: 1305-1308.
38. Cai S, Singh BR, Sharma S. Botulism diagnostics: from clinical symptoms to in vitro assays. Crit Rev Microbiol 2007; 33: 109-125.
39. Horowitz BZ. Botulinum toxin. Crit Care Clin 2005; 21: 825-839, viii.
40. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al.; Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001; 285: 1059-1070.
41. Ting PT, Freiman A. The story of Clostridium botulinum: from food poisoning to Botox. Clin Med 2004; 4: 258-261.
42. Lamb A. Biological weapons: the facts not the fiction. Clin Med 2001; 1: 502-504.
43. Hauschild. Clostridium botulinum. In: Doyle M, editor. Foodborne Bacterial Pathogens. New York: Marcel Dekker; 1989:112-189.
44. Hatheway CL. Clostridium botulinum and other clostridia that produce botulinum neurotoxin. In: Hauschild AH, Dodds KL, editors. Clostridium botulinum: Ecology and Control in Foods. New York: Marcel Dekker; 1992:3-20.
45. Hatheway CL. Clostridium botulinum. In: Bartlett JG, Blacklow NR, editors. Infectious Diseases. Orlando: Saunders Company; 1991: 1583-1586.
46. Hatheway CL. Botulism: the present status of the disease. Curr Top Microbiol Immunol 1995; 195: 55-75.
47. Caya JG, Agni R, Miller JE. Clostridium botulinum and the clinical laboratorian: a detailed review of botulism, including biological warfare ramifications of botulinum toxin. Arch Path Lab Med 2004; 128: 653-662.
48. Therre H. Le botulisme en Europe. Euro Surveill 1999; 4: 2-7.
49. Sobel J, Tucker N, Sulka A, McLaughlin J, Maslanka S. Food borne botulism in the United States, 1990-2000. Emerg Infect Dis 2004; 10: 1606-1611.
50. Barrett DH. Endemic food-borne botulism: clinical experience, 1973-1986 at Alaska Native Medical Center. Alaska Med 1991; 33: 101-108.
51. Sobel J. Botulism. Clin Infect Dis 2005; 41: 1167-1173.
52. Dolman CE, Iida H. Type E botulism: its epidemiology, prevention and specific treatment. Can J Pub Health 1963; 54: 293-308.
53. Infectious Disease Surveillance Center. Botulism, Japan. Infectious Agents Surveillance Report 2000; 21: 241. Available at: http://idsc. nih.go.jp/iasr/21/241/tpc241.html.
54. Shih Y, Chao SY. Botulism in China. Rev Infect Dis 1986; 8: 984-990.
55. Quenum B, Hubert B, Sebald M. Le Botulisme en 1987 et 1988. Bull Epidemiol Hebdomadaire 1989; 27: 109-110.
56. Centers for Diseases Control. Botulism in the United States 1897-1973. Handbook for Epidemiologists, Clinicians and Laboratory Workers. Atlanta: CDC; 1974.
57. Wainwright RB, Heyward WL, Middaugh JP, Hatheway CL, Harpster AP, Bender TR. Food-borne botulism in Alaska, 1947- 1985: epidemiology and clinical findings. J Infect Dis 1988; 157: 1158-1162.
58. McLauchlin J, Grant KA, Little CL. Food-borne botulism in the United Kingdom. J Public Health (Oxf) 2006; 28: 337-342.
59. United States Public Health Service. Botulism in the United States, 1899-1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Atlanta: Centers for Disease Control and Prevention 1998, 7-8.
60. Craig JM, Iida H, Inoue K. A recent case of botulism in Hokkaido, Japan. Jpn J Med Sci Biol 1970; 23: 193-198.
61. Lecour H, Ramos MH, Almeida B, Barbosa R. Food-borne botulism. A review of 13 outbreaks. Arch Intern Med 1988; 148: 579-580.
62. Hauschild A. Botulism in Canada: summary for 1984. Can Med Assoc J 1985; 132: 1402.
63. Pourtaghva M, Machoun A, Fatollah-Zadeh, Khodadoust A, Taeb H, Farzam H, Farhangui, Kodari, Daiar, Saadat. Le botulisme en Iran. Med Mal Infect 1975; 5: 536-539.
64. Woodruff BA, Griffin PM, McCroskey LM, Smart JF, Wainwright RB, Bryant RG, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975- 1988. J Infect Dis 1992; 166: 1281-1286.
65. Boyer A, Salah A. Le botulisme en France: epidemiologie et clinique. Pyrexie 2000; 6: 177-183.
66. Roblot P, Roblot F, Fauchère JL, Devilleger A, Maréchaud R, Breux JP, et al. Retrospective study of 108 cases of botulism in Poitiers, France. J Med Microbiol 1994; 40: 379-384.
67. Chiorboli E, Fortina G, Bona G. Flaccid paralysis caused by botulinum toxin type B after pesto ingestion. Pediatr Infect Dis J 1997; 16: 725-726.
68. Roberts E, Wales JM, Brett MM, Bradding P. Cranial-nerve palsies and vomiting. Lancet 1998; 352: 1674.
69. Pourshafie MR, Saifie M, Shafiee A, Vahdani P, Aslani M, Salemian J. An outbreak of food-borne botulism associated with contaminated locally made cheese in Iran. Scand J Infect Dis 1998; 30: 92-94.
70. Villar RG, Shapiro RL, Busto S, Riva-Posse C, Verdejo G, Farace MI, et al. Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina. JAMA 1999; 281: 1334-1340.
71. Centers for Disease Control and Prevention (CDC). Foodborne botulism associated with home-canned bamboo shoots - Thailand, 1998. MMWR Morb Mortal Wkly Rep 1999; 48:437-439.
72. Centers for Disease Control and Prevention (CDC). Botulism outbreak associated with eating fermented food - Alaska, 2001. MMWR Morb Mortal Wkly Rep 2001; 50:680-682.
73. Abgueguen P, Delbos V, Chennebault JM, Fanello S, Brenet O, Alquier P, et al. Nine cases of foodborne botulism type B in France and literature review. Eur J Clin Microbiol Infect Dis 2003; 22:749-752.
74. Lindström M, Hielm S, Nevas M, Tuisku S, Korkeala H. Proteolytic Clostridium botulinum type B in the gastric content of a patient with type E botulism due to whitefish eggs. Foodborne Pathog Dis 2004; 1:53-57.
75. McLaughlin JB. Botulism type E outbreak associated with eating a beached whale, Alaska. Emerg Infect Dis 2004; 10:1685-1687.
76. Varma JK, Katsitadze G, Moiscrafishvili M, Zardiashvili T, Chikheli M, Tarkashvili N, et al. Foodborne botulism in the Republic of Georgia. Emerg Infect Dis 2004; 10:1601-1605.
77. Tseng CK, Tsai CH, Tseng CH, Tseng YC, Lee FY, Huang WS. An outbreak of foodborne botulism in Taiwan. Int J Hyg Environ Health 2009; 212:82-86.
78. Seals JE, Snyder JD, Edell TA, Hatheway CL, Johnson CJ, Swanson RC, Hughes JM. Restaurant-associated type A botulism: transmission by potato salad. Am J Epidemiol 1981; 113:436-444.
79. MacDonald KL, Spengler RF, Hatheway CL, Hargrett NT, Cohen ML. Type A botulism from sauteed onions. Clinical and epidemio-logic observations. JAMA 1985; 253:1275-1278.
80. Centers for Disease Control (CDC). Restaurant-associated botulism from mushrooms bottled in-house - Vancouver, British Columbia, Canada. MMWR Morb Mortal Wkly Rep 1987; 36:103.
81. Morse DL, Pickard LK, Guzewich JJ, Devine BD, Shayegani M. Garlic-in-oil associated botulism: episode leads to product modification. Am J Public Health 1990; 80:1372-1373.
82. Bhutani M, Ralph E, Sharpe MD. Acute paralysis following "a bad potato": a case of botulism. Can J Anaesth 2005; 52:433-436.
83. Cawthorne A, Celentano LP, D'Ancona F, Bella A, Massari M, Anniballi F, et al. Botulism and preserved green olives. Emerg Infect Dis 2005; 11:781-782.
84. Chou JH, Hwang PH, Malison MD. An outbreak of type A foodborne botulism in Taiwan due to commercially preserved peanuts. Int J Epidemiol 1988; 17:899-902.
85. O'Mahony M, Mitchell E, Gilbert RJ, Hutchinson DN, Begg NT, Rodhouse JC, Morris JE. An outbreak of foodborne botulism associated with contaminated hazelnut yoghurt. Epidemiol Infect 1990; 104:389-395.
86. Slater PE, Addiss DG, Cohen A, Leventhal A, Chassis G, Zehavi H, et al. Foodborne botulism: an international outbreak. Int J Epidemiol 1989; 18:693-696.
87. Weber JT, Hibbs RG Jr, Darwish A, Mishu B, Corwin AL, Rakha M, et al. A massive outbreak of type E botulism associated with traditional salted fish in Cairo. J Infect Dis 1993; 167:451-454.
88. Centers for Disease Control (CDC). Outbreak of type E botulism associated with an uneviscerated, salt-cured fish product - New Jersey, 1992. MMWR Morb Mortal Wkly Rep 1992; 41: 521-522.
89. Centers for Disease Control and Prevention (CDC). Type B botulism associated with roasted eggplant in oil - Italy, 1993. MMWR Morb Mortal Wkly Rep 1995; 44:33-36.
90. Troillet N, Praz G. Epidemic of type B botulism: Sion, December 1993-January 1994. Schweiz Med Wochenschr 1995; 125:1805-1812.
91. Townes JM, Cieslak PR, Hatheway CL, Solomon HM, Holloway JT, Baker MP, et al. An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med 1996; 125:558-563.
92. Aureli P, Franciosa G, Pourshaban M. Foodborne botulism in Italy. Lancet 1996; 348:1594.
93. Franciosa G, Pourshaban M, Gianfranceschi M, Gattuso A, Fenicia L, Ferrini AM, et al. Clostridium botulinum spores and toxin in mascarpone cheese and other milk products. J Food Prot 1999; 62:867-871.
94. Aureli P, Di Cunto M, Maffei A, De Chiara G, Franciosa G, Accorinti L, et al. An outbreak in Italy of botulism associated with a dessert made with mascarpone cream cheese. Eur J Epidemiol 2000; 16:913-918.
95. Ouagari Z, Chakib A, Sodqi M, Marih L, Marhoum Filali K, Benslama A, et al. Botulism in Casablanca (11 cases). Bull Soc Pathol Exot 2002; 95:272-275.
96. Kalluri P, Crowe C, Reller M, Gaul L, Hayslett J, Barth S, et al. An outbreak of foodborne botulism associated with food sold at a salvage store in Texas. Clin Infect Dis 2003; 37:1490-1495.
97. Frean J, Arntzen L, van den Heever J, Perovic O. Fatal type A botulism in South Africa, 2002. Trans R Soc Trop Med Hyg 2004; 98:290-295.
98. Richardson WH, Frei SS, Williams SR. A case of type F botulism in southern California. J Toxicol Clin Toxicol 2004; 42:383-387.
99. Korkeala H, Stengel G, Hyytiä E, Vogelsang B, Bohl A, Wihlman H, et al. Type E botulism associated with vacuum-packaged hot-smoked whitefish. Int J Food Microbiol 1998; 43:1-5.
100. Lindstrom M, Vuorela M, Hinderink K, Korkeala H, Dahlsten E, Raahenmaa M, Kuusi M. Botulism associated with vacuum-packed smoked whitefish in Finland, June-July 2006. Euro Surveill 2006; 11:E060720.3.
101. King LA; French Multidisciplinary Outbreak Investigation Team. Two severe cases of botulism associated with industrially produced chicken enchiladas, France, August 2008. Euro Surveill 2008; 13.pii:18978.
102. Sheth AN, Wiersma P, Atrubin D, Dubey V, Zink D, Skinner G, et al. International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice. Clin Infect Dis 2008; 47:1245-1251.
103. Habermann E. Clostridial neurotoxins and the central nervous system: functional studies on isolated preparations. In: Simpson LL, editor. Botulinum Neurotoxin and Tetanus Toxin. New York: Academic Press; 1989:53-67.
104. Hughes JM, Blumenthal JR, Merson MH, Lombard GL, Dowell VR Jr, Gangarosa EJ. Clinical features of types A and B foodborne botulism. Ann Intern Med 1981; 95:442-445.
105. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 1998; 129:221-228.
106. Domingo RM, Haller JS, Gruenthal M. Infant botulism: two recent cases and literature review. J Child Neurol 2008; 23:1336-1346.
107. Brook I. Infant botulism. J Perinatol 2007; 27:175-180.
108. Fenicia L, Anniballi F. Infant botulism. Ann Ist Super Sanita 2009; 45:134-146.
109. Francisco AM, Arnon SS. Clinical mimics of infant botulism. Pediatrics 2007; 119:826-828.
110. Holzer E. Botulism caused by inhalation. Med Klin 1962; 57:1735-1738.
111. Tugnoli V, Eleopra R, Qyatrale R, Capone JG, Sensi M, Gastaldo E. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol 2002; 147:808-809. (Pubitemid 35286177)
112. Beseler-Soto B, Sánchez-Palomares M, Santos-Serrano L, Landa-Rivera L, Sanantonio-Valdearcos F, Paricio-Talayero JM. Iatrogenic botulism: a complication to be taken into account in the treatment of child spasticity. Rev Neurol 2003; 37:444-446.
113. Witoonpanich R, Vichayanrat E, Tantisiriwit K, Wongtanate M, Sucharitchan N, Oranrigsupak P, et al. Survival analysis for respiratory failure in patients with food-borne botulism. Clin Toxicol (Phila) 2010; 48:177-183.
114. Brook I. Botulism: the challenge of diagnosis and treatment. Rev Neurol Dis 2006; 3:182-189.
115. Weber JT, Goodpasture HC, Alexander H, Werner SB, Hatheway CL, Tauxe RV. Wound botulism in a patient with a tooth abscess: case report and review. Clin Infect Dis 1993; 16:635-639.
116. Robinson RF, Nahata MC. Management of botulism. Ann Pharmacother 2003; 37:127-131.
117. Lindström M, Korkeala H. Laboratory diagnostics of botulism. Clin Microbiol Rev 2006; 19:298-314.
118. Horwitz MA, Marr JS, Merson MH, Dowell VR, Ellis JM. A continuing common-source outbreak of botulism in a family. Lancet 1975; 2:861-863.
119. Koenig MG, Spickard A, Cardella MA, Rogers DE. Clinical and laboratory observations on type E Botulism in man. Medicine (Baltimore) 1964; 43:517-545.
120. Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, Bronze MS. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002; 323:326-340.
121. Armada M, Love S, Barrett E, Monroe J, Peery D, Sobel J. Foodborne botulism in a six-month-old infant caused by home-canned baby food. Ann Emerg Med 2003; 42:226-229.
122. Lund BM. Foodborne disease due to Bacillus and Clostridium species. Lancet 1990; 336:982-986.
123. Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998; 21:701-710.
124. Hauschild AH, Gauvreau L. Food borne botulism in Canada, 1971- 84. Can Med Assoc J 1985; 133:1141-1146.
125. Gelli DS, Jakabi M, Souza A. Botulism: a laboratory investigation on biological and food samples from cases and outbreaks in Brazil (1982-2001). Rev Inst Med Trop Sao Paulo 2002; 44:321-324.
126. Goldfrank LR, Geyer HL. Botulinum Antitoxin. In: Goldfrank's Toxicologic Emergencies (Ninth Edition) by Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. New York: McGraw-Hill; 2010: 695-697.
127. Shapiro RL, Hatheway C, Becher J, Swerdlow DL. Botulism surveillance and emergency response: a public health strategy for a global challenge. JAMA 1997; 278:433-435.
128. Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A food borne botulism. Am J Med 1984; 76:794-798.
129. Centers for Disease Control and Prevention (CDC). Investigational Heptavalent Botulinum Antitoxin (HBAT) to Replace Licensed Botulinum Antitoxin AB and Investigational Botulinum Antitoxin E. MMWR Morb Mortal Wkly Rep 2010; 59:299.
130. McLaughlin J, Funk B. New Recommendations for Use of Heptavalent Botulinum antitoxin (H-BAT). State of AK Bull 2010; 5:1.
131. Thompson JA, Filloux FM, Van Orman CB, Swoboda K, Peterson P, Firth SD, Bale JF Jr. Infant botulism in the age of botulism immune globulin. Neurology 2005; 64:2029-2032.
132. Long SS. Infant botulism. Pediatr Infect Dis J 2001; 20:707-709.
133. Horowitz BZ. Polar poisons: did botulism doom the Franklin expedition? J Toxicol Clin Toxicol 2003; 41:841-847.
134. Erlich P. Die werthbemessung des diphtheria heil-serum und deren theoretische grundlagen. Klin Jahrb Jena 1897; 6:299-326.
135. Clayton MA, Clayton JM, Brown DR, Middlebrook JL. Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infect Immun 1995; 63:2738-2742.
136. Bennett AM, Perkins SD, Holley JL. DNA vaccination protects against botulinum neurotoxin type F. Vaccine 2003; 21:3110-3117.
137. Weinberg M, Goy P. Recherches sur la toxine botulinque. Compt Rend Soc Biol 1924; 90: 269-271.
138. Ramon G. Pouvior floculant et pouvoir toxique de la toxine diphterique. Compt Rend de la Soc de Biol Paris 1923; 89: 2-4.
139. Nigg C, Hottle CA, Coriell LL, Rosenwald AS, Beveridge GW. Studies on botulinum toxoid, types A and B. I. Production of alum-precipitated toxoids. J Immunol 1947; 55: 245-254.
140. Fiock MA, Cardella MA, Gearinger NF. Studies on immunity to toxins of Clostridium botulinum. IX. Immunologic response of man to purified ABCDE botulinum toxoid. J Immunol 1963; 90: 667-702.
141. Ellis RJ. Immunobiologic agents and drugs available from the Centers for Disease Control: description, recommendations, adverse events, and serologic response. 3rd ed. Atlanta: Centers for Disease Control; 1982. 1.
142. Byrne MP, Smith LA. Development of vaccines for prevention of botulism. Biochimie 2000; 82: 955-966.
143. Fairweather NF, Lyness VA, Maskell DJ. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect Immun 1987; 55: 2541-2545.
144. Smith LA, Rusnak JM. Botulinum neurotoxin vaccines: past, present, and future. Crit Rev Immunol 2007; 27: 303-318.
145. Smith LA, Jensen MJ, Montgomery VA, Brown DR, Ahmed SA, Smith TJ. Roads from vaccines to therapies. Mov Disord 2004; 19 (Suppl 8):S48-S52.
146. Cai S, Singh BR. Strategies to design inhibitors of Clostridium botulinum neurotoxins. Infect Disord Drug Targets 2007; 7: 47-57.
147. Byrne MP, Smith LA. Development of vaccines for prevention of botulism. Biochimie 2000; 82: 955-966.
148. Rusnak JM, Smith LA. Botulinum neurotoxin vaccines: past history and recent developments. Hum Vaccin 2009; 5: 794-805.